Impact of MGMT and ABCB1 single nucleotide polymorphisms on temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma

被引:0
|
作者
Jamelot, M. [1 ]
Fontanilles, M. [1 ]
Lequesne, J. [2 ]
Pepin, L-F. [2 ]
Lorivel, S. [2 ]
Alexandru, C. [1 ]
Tennevet, I. [1 ]
Clatot, F. [1 ]
Di Fiore, F. [3 ]
Lamoureux, F. [4 ]
机构
[1] Canc Ctr Henri Becquerel, Dept Med Oncol, Rouen, France
[2] Canc Ctr Henri Becquerel, Clin Res, Rouen, France
[3] CHU Charles Nicolle, Gastroenterol, Rouen, France
[4] CHU Charles Nicolle, Serv Pharmacol Toxicol, Rouen, France
关键词
D O I
10.1016/j.annonc.2020.08.488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
379P
引用
收藏
页码:S403 / S403
页数:1
相关论文
共 50 条
  • [1] SECONDARY PROPHYLAXIS WITH ROMIPLOSTIM FOR TEMOZOLOMIDE-INDUCED THROMBOCYTOPENIA IN NEWLY DIAGNOSED GLIOBLASTOMA
    Le Rhun, E.
    Devos, P.
    Houillier, C.
    Cartalat-Carel, S.
    Chinot, O.
    Di Stefano, A.
    Reyns, N.
    Dubois, F.
    Weller, M.
    NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [2] Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
    Le Rhun, Emilie
    Devos, Patrick
    Houillier, Caroline
    Cartalat-Carel, Stephanie
    Chinot, Olivier L.
    Di Stefano, Anna Luisa
    Dib, Malek
    Reyns, Nicolas
    Dubois, Francois
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] ABCB1 single nucleotide polymorphisms in the Brazilian population
    Marcos Antonio Mauricio Scheiner
    Arthur Motta Damasceno
    Raquel Ciuvalschi Maia
    Molecular Biology Reports, 2010, 37 : 111 - 118
  • [4] ABCB1 single nucleotide polymorphisms in the Brazilian population
    Mauricio Scheiner, Marcos Antonio
    Damasceno, Arthur Motta
    Maia, Raquel Ciuvalschi
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 111 - 118
  • [5] ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
    Annika Malmström
    Malgorzata Łysiak
    Lisa Åkesson
    Ingrid Jakobsen
    Munila Mudaisi
    Peter Milos
    Martin Hallbeck
    Victoria Fomichov
    Helle Broholm
    Kirsten Grunnet
    Hans Skovgaard Poulsen
    Charlotte Bratthäll
    Michael Strandeus
    Angeliki Papagiannopoulou
    Marie Stenmark-Askmalm
    Henrik Green
    Peter Söderkvist
    The Pharmacogenomics Journal, 2020, 20 : 213 - 219
  • [6] ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
    Malmstrom, Annika
    Lysiak, Malgorzata
    akesson, Lisa
    Jakobsen, Ingrid
    Mudaisi, Munila
    Milos, Peter
    Hallbeck, Martin
    Fomichov, Victoria
    Broholm, Helle
    Grunnet, Kirsten
    Poulsen, Hans Skovgaard
    Bratthall, Charlotte
    Strandeus, Michael
    Papagiannopoulou, Angeliki
    Stenmark-Askmalm, Marie
    Green, Henrik
    Soderkvist, Peter
    PHARMACOGENOMICS JOURNAL, 2020, 20 (02): : 213 - 219
  • [7] Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study
    Prithwijit Moitra
    Abhishek Chatterjee
    Priti Khatri Kota
    Sridhar Epari
    Vijay Patil
    Archya Dasgupta
    Pradnya Kowtal
    Rajiv Sarin
    Tejpal Gupta
    Journal of Neuro-Oncology, 2022, 156 : 625 - 634
  • [8] Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study
    Moitra, Prithwijit
    Chatterjee, Abhishek
    Kota, Priti Khatri
    Epari, Sridhar
    Patil, Vijay
    Dasgupta, Archya
    Kowtal, Pradnya
    Sarin, Rajiv
    Gupta, Tejpal
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 625 - 634
  • [9] A MDR1 (ABCB1) GENE SINGLE NUCLEOTIDE POLYMORPHISM PREDICTS OUTCOME OF TEMOZOLOMIDE TREATMENT IN GLIOBLASTOMA PATIENTS
    Krex, Dietmar
    Kestel, Lydia
    Robel, Katja
    Kramer, Michael
    Schaich, Markus
    NEURO-ONCOLOGY, 2009, 11 (06) : 959 - 959
  • [10] A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
    Schaich, M.
    Kestel, L.
    Pfirrmann, M.
    Robel, K.
    Illmer, T.
    Kramer, M.
    Dill, C.
    Ehninger, G.
    Schackert, G.
    Krex, D.
    ANNALS OF ONCOLOGY, 2009, 20 (01) : 175 - 181